Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
2021
Abstract Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) th...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
12
References
91
Citations
NaN
KQI